Details of the Drug

General Information of Drug (ID: DM6P15C)

Drug Name

EA-230

Synonyms

503844-09-5; (2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-methylbutanoic acid; L-Valine, L-alanyl-L-glutaminylglycyl-; DTXSID80436085

Indication

Disease Entry	ICD 11	Status	REF
Acute kidney injury	GB60	Phase 2	[1]
Bacillus anthracis infection	1G40	Phase 2	[2]
------------------------------------------------------------------------------------

Drug Type

Peptide

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C15H27N5O6
Canonical SMILES: CC(C)C(C(=O)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C)N
InChI: 1S/C15H27N5O6/c1-7(2)12(15(25)26)20-11(22)6-18-14(24)9(4-5-10(17)21)19-13(23)8(3)16/h7-9,12H,4-6,16H2,1-3H3,(H2,17,21)(H,18,24)(H,19,23)(H,20,22)(H,25,26)/t8-,9-,12-/m0/s1
InChIKey: DXRXYJYFADHAPA-AUTRQRHGSA-N

Cross-matching ID

PubChem CID: 10133920
CAS Number: 503844-09-5
TTD ID: DL51QK

References

1	Clinical pipeline report, company report or official report of Exponential Biotherapies.
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800041723)